| Ytd | 3.26% | |
| 1y | 9.17% |
| Open | 60.41 | Prev Close | 61.25 | Low | 60.41 | High | 61.61 | Mkt Cap | 3.30B |
| Vol | 5.01K | Avg Vol | 790.92K | EPS | 4.52 | P/E | 13.58 | Forward P/E | 11.47 |
| Beta | 0.98 | Short Ratio | 2.33 | Inst. Own | 108.68% | Dividend | 0.98 | Div Yield | 1.66 |
| Ex Div Date | 07-30 | Earning | 09-23 | 50-d Avg | 59.41 | 200-d Avg | 60.12 | 1yr Est | 73.29 |
Investors interested in Chemical - Specialty stocks are likely familiar with H. B. Fuller (FUL) and
Improving demand in major end markets augurs well for The Zacks Chemicals Specialty industry. ESI, F
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
Fifth Third Bancorp increased its holdings in shares of H. B. Fuller Company (NYSE: FUL) by 3,222.9%
Dimensional Fund Advisors LP raised its stake in H. B. Fuller Company (NYSE: FUL) by 5.4% in the und
H. B. Fuller (FUL) reported earnings 30 days ago. What's next for the stock?
Investors interested in Chemical - Specialty stocks are likely familiar with H. B. Fuller (FUL) and
CLDT, PARR, ARCO, CAL and FUL stand out with attractive EV-to-EBITDA ratios and strong earnings outl
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
H.B. Fuller Company (NYSE: FUL) today announced that its Board of Directors declared a regular quart
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL) today announced that its Board of
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
FUL is tapping medical, aerospace and pricing trends to support margins, but volume weakness still c
FUL trades near the low end of its five-year valuation range as improving earnings meet volume, infl
FUL's outlook rests on pricing, margins and portfolio reshaping as medical expansion and M&A aim to
The materials sector has oversold stocks that may offer a buying opportunity. RSI compares a stock&#
Investors interested in stocks from the Chemical - Specialty sector have probably already heard of H
Citigroup analyst Patrick Cunningham maintains H.B. Fuller (NYSE:FUL) with a Buy and raises the p
Deutsche Bank analyst David Begleiter maintains H.B. Fuller (NYSE:FUL) with a Buy and raises the
FUL flags stronger pricing, higher profit guidance and a proposed AMS deal aimed at expanding its me
JP Morgan analyst Jeffrey Zekauskas upgrades H.B. Fuller (NYSE:FUL) from Neutral to Overweight an
H.B. Fuller is rated a "buy" with a conservative $80/share price target, reflecting improved fundame
H.B. Fuller Company (FUL) Q2 2026 Earnings Call Transcript
H.B. Fuller (NYSE:FUL) reported second-quarter financial results on Thursday. The transcript from th
H.B. Fuller shares fell premarket as investors weighed its AMS acquisition, Q2 earnings beat, raised
U.S. stock futures rose on Thursday, as the Dow Jones, Nasdaq 100, and S&P 500 indices rose, fol
CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group, LLC (collectively with its affiliates, “Ancora” o
U.S. stock futures up, Nasdaq 100 futures gain 2%. H.B. Fuller shares dip 8.3% on earnings release a
Extends capabilities in attractive, high-growth medical segmentsAccelerates portfolio mix shift and
U.S. stock futures up, TD Synnex, Micron, Darden, H.B. Fuller, and Acuity expected to report earning
H.B. Fuller (NYSE:FUL) reported quarterly earnings of $1.41 per share which beat the analyst consens
Companies Reporting Before The Bell • Crown Crafts (NASDAQ:CRWS) is estimated to report earnings for
H.B. Fuller (FUL) to report Q2 earnings on June 24. Analysts expect $1.38/share, company increased d
UBS analyst Lucas Beaumont maintains H.B. Fuller (NYSE:FUL) with a Neutral and raises the price t
JP Morgan analyst Jeffrey Zekauskas upgrades H.B. Fuller (NYSE:FUL) from Underweight to Neutral a
H.B. Fuller (NYSE:FUL) today issued the following statement:"Our Board and management team value
https://www.bloomberg.com/news/articles/2026-05-21/h-b-fuller-said-to-bid-over-600-million-for-ams-i
H.B. Fuller Company (NYSE: FUL) today announced that its Board of Directors approved an increase in
Citigroup analyst Patrick Cunningham maintains H.B. Fuller (NYSE:FUL) with a Buy and raises the p
UBS analyst Lucas Beaumont maintains H.B. Fuller (NYSE:FUL) with a Neutral and lowers the price t
H.B. Fuller (NYSE:FUL) reported quarterly earnings of $0.57 per share which beat the analyst consens
H.B. Fuller (NYSE: FUL) will release Q1 earnings on March 25, with expectations of 55 cents/share an
H.B. Fuller (NYSE:FUL), the largest pureplay adhesives company in the world, today announced a globa
Citigroup analyst Patrick Cunningham maintains H.B. Fuller (NYSE:FUL) with a Buy and lowers the p
The oversold opportunity to buy undervalued materials stocks with the RSI below 30: Stepan Co (NYSE:
Citigroup analyst Patrick Cunningham maintains H.B. Fuller (NYSE:FUL) with a Buy and raises the p
UBS analyst Lucas Beaumont maintains H.B. Fuller (NYSE:FUL) with a Neutral and raises the price t
H.B. Fuller (NYSE:FUL) is looking for FY2026 Adj EPS of $4.35-$4.70 vs $4.19 analyst estimate. sees